Michael Patrick Miller

CIK: 0001236514

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

PBYI

PUMA BIOTECHNOLOGY, INC.

Director

RIGL

RIGEL PHARMACEUTICALS INC

Director

BTAI

BioXcel Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 11, 2026
Award(A)
Direct
27K shares-
RIGL
RIGEL PHARMACEUTICALS INC
May 15, 2026
Award(A)
Direct
5.8K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 1, 2026
Award(A)
Stock Option (right to buy)
Direct
12K shares-
BTAI
BioXcel Therapeutics, Inc.
Jan 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
17K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Nov 11, 2025
Sale(S)
Direct
20K shares at avg. $4.86$97K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jun 11, 2025
Award(A)
Direct
27K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	27,000	-	$0	Direct
May 15, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	5,750	-	$0	Direct
Feb 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Stock Option (right to buy)	12,000	-	-	Direct
Jan 9, 2026	BTAI BioXcel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	17,000	-	-	Direct
Nov 11, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	20,000	$4.86	$97,228	Direct
Jun 11, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	27,000	-	-	Direct

1-6 of 6 transactions

About MILLER MICHAEL PATRICK

MILLER MICHAEL PATRICK (SEC CIK 0001236514) files insider reports with the SEC as Director of PUMA BIOTECHNOLOGY, INC. (PBYI), Director of RIGEL PHARMACEUTICALS INC (RIGL) and Director of BioXcel Therapeutics, Inc. (BTAI).

Signal8 holds 7 ownership filings by MILLER MICHAEL PATRICK (1 Form 3, 6 Form 4), filed between Jun 13, 2025 and Jun 15, 2026. Those filings report 6 transactions, from Jun 11, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MILLER MICHAEL PATRICK's filings is in LOS ANGELES, CA.

Recent filings by MILLER MICHAEL PATRICK

Jun 11, 2026: Grant or award of PBYI shares (Form 4, code A).
May 15, 2026: Grant or award of RIGL shares (Form 4, code A).
Feb 1, 2026: Grant or award of RIGL derivative securities (Form 4, code A).
Jan 9, 2026: Grant or award of BTAI derivative securities (Form 4, code A).
Nov 11, 2025: Open-market sale of PBYI shares (Form 4, code S).

Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)

WILSON TROY EDWARD, Director
Cesano Alessandra, Director
AUERBACH ALAN H, President and CEO
HUNT DOUGLAS M
NOUGUES MAXIMO F, Chief Financial Officer
Stuglik Brian M, Director

How to read Form 4 transaction codes